{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:28:04Z","timestamp":1789684084933,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011284","name":"Valeant Pharmaceuticals International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011284","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.japh.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T17:49:22Z","timestamp":1594748962000},"page":"892-898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating trajectories of statin adherence after a motivational interviewing intervention"],"prefix":"10.1016","volume":"60","author":[{"given":"Rutugandha","family":"Paranjpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Vadhariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. James","family":"Essien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara W.","family":"Esse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-8523","authenticated-orcid":false,"given":"Susan","family":"Abughosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.japh.2020.06.011_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjms.2016.01.010","article-title":"Medication adherence: truth and consequences","volume":"351","author":"Brown","year":"2016","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.japh.2020.06.011_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","article-title":"Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence","volume":"51","author":"Franklin","year":"2013","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.japh.2020.06.011_bib3","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/cpt.865","article-title":"Group-based trajectory models: assessing adherence to antihypertensive medication in older adults in a community pharmacy setting","volume":"103","author":"Dillon","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.japh.2020.06.011_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/pds.1671","article-title":"Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients","volume":"17","author":"Choudhry","year":"2008","journal-title":"Pharmacoepidem. Drug Safe"},{"issue":"20","key":"10.1016\/j.japh.2020.06.011_bib5","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/archinte.165.20.2414","article-title":"Compliance with osteoporosis medications","volume":"165","author":"Solomon","year":"2005","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.japh.2020.06.011_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-5151(03)00091-4","article-title":"Adherence to long-term therapies: evidence for action","volume":"2","author":"De Geest","year":"2003","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.japh.2020.06.011_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-033","article-title":"The unmet challenge of medication nonadherence","volume":"22","author":"Kleinsinger","year":"2018","journal-title":"Perm J"},{"key":"10.1016\/j.japh.2020.06.011_bib8","series-title":"Avoidable Costs in US Health Care","year":"2013"},{"issue":"11","key":"10.1016\/j.japh.2020.06.011_bib9","article-title":"Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial","volume":"6","author":"Nguyen","year":"2016","journal-title":"BMJ, (Open)"},{"issue":"7","key":"10.1016\/j.japh.2020.06.011_bib10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/0962280216673085","article-title":"Group-based multi-trajectory modeling","volume":"27","author":"Nagin","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"2\u20133","key":"10.1016\/j.japh.2020.06.011_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000360229","article-title":"Group-based trajectory modeling: an overview","volume":"65","author":"Nagin","year":"2014","journal-title":"Ann Nutr Metab"},{"issue":"8","key":"10.1016\/j.japh.2020.06.011_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161381","article-title":"Medication adherence patterns after hospitalization for coronary heart disease. A population-based study using electronic records and group-based trajectory models","volume":"11","author":"Librero","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.japh.2020.06.011_bib13","first-page":"e197","article-title":"Factors affecting medication adherence trajectories for patients with heart failure","volume":"21","author":"Juarez","year":"2015","journal-title":"Am J Manag Care"},{"issue":"10","key":"10.1016\/j.japh.2020.06.011_bib14","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","article-title":"Patterns of glaucoma medication adherence over four years of follow-up","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.japh.2020.06.011_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamainternmed.2014.7889","article-title":"Functional trajectories among older persons before and after critical illness","volume":"175","author":"Ferrante","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.japh.2020.06.011_bib16","first-page":"1053","article-title":"Enhancing statin adherence using a motivational interviewing intervention and past adherence trajectories in patients with suboptimal adherence","volume":"25","author":"Abughosh","year":"2019","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.japh.2020.06.011_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.japh.2020.06.011_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7812\/TPP\/09-090","article-title":"Patients\u2019 perspectives on nonadherence to statin therapy: a focus-group study","volume":"14","author":"Fung","year":"2010","journal-title":"Perm J"},{"issue":"5","key":"10.1016\/j.japh.2020.06.011_bib19","first-page":"404","article-title":"Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients","volume":"10","author":"Abughosh","year":"2004","journal-title":"J\u00a0Manag Care Pharm"},{"issue":"4","key":"10.1016\/j.japh.2020.06.011_bib21","first-page":"202","article-title":"Group-based trajectory models to identify sociodemographic and clinical predictors of adherence patterns to statin therapy among older adults","volume":"12","author":"Vadhariya","year":"2019","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.japh.2020.06.011_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"issue":"9","key":"10.1016\/j.japh.2020.06.011_bib23","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s11606-016-3747-6","article-title":"Trajectories of diabetes medication adherence and hospitalization risk: a retrospective cohort study in a large state Medicaid program","volume":"31","author":"Lo-Ciganic","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"issue":"6","key":"10.1016\/j.japh.2020.06.011_bib24","first-page":"678","article-title":"Medication adherence to antihypertensive triple-combination therapy among patients enrolled in a Medicare Advantage plan","volume":"25","author":"Wang","year":"2019","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"10","key":"10.1016\/j.japh.2020.06.011_bib25","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pds.3787","article-title":"Association between trajectories of statin adherence and subsequent cardiovascular events","volume":"24","author":"Franklin","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.japh.2020.06.011_bib26","first-page":"549","article-title":"A\u00a0motivational interviewing intervention by pharmacy students to improve medication adherence","volume":"23","author":"Abughosh","year":"2017","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"3","key":"10.1016\/j.japh.2020.06.011_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09540120701593489","article-title":"Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study","volume":"20","author":"DiIorio","year":"2008","journal-title":"AIDS Care"},{"issue":"10","key":"10.1016\/j.japh.2020.06.011_bib28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ajh.2008.240","article-title":"A\u00a0practice-based trial of motivational interviewing and adherence in hypertensive African Americans","volume":"21","author":"Ogedegbe","year":"2008","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.japh.2020.06.011_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/dc14-2098","article-title":"Determinants of adherence to diabetes medications: findings from a large pharmacy claims database","volume":"38","author":"Kirkman","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.japh.2020.06.011_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MLR.0b013e31827da5b9","article-title":"Continuity of care, medication adherence, and health care outcomes among patients with newly diagnosed type 2 diabetes: a longitudinal analysis","volume":"51","author":"Chen","year":"2013","journal-title":"Med Care"},{"issue":"10","key":"10.1016\/j.japh.2020.06.011_bib31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/phar.1994","article-title":"Relationships between medication adherence and cardiovascular disease risk factor control in elderly patients with diabetes","volume":"37","author":"Raebel","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.japh.2020.06.011_bib32","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s11096-019-00895-3","article-title":"Exploring variables associated with medication non-adherence in patients with COPD","volume":"41","author":"Jarab","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"10.1016\/j.japh.2020.06.011_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3121\/cmr.2013.1113","article-title":"Patient characteristics associated with medication adherence","volume":"11","author":"Rolnick","year":"2013","journal-title":"Clin Med Res"},{"issue":"11","key":"10.1016\/j.japh.2020.06.011_bib34","first-page":"1146","article-title":"Using previous medication adherence to predict future adherence","volume":"24","author":"Kumamaru","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"5","key":"10.1016\/j.japh.2020.06.011_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.japh.2020.06.011_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00002512-200522030-00005","article-title":"Assessing medication adherence in the elderly: which tools to use in clinical practice?","volume":"22","author":"MacLaughlin","year":"2005","journal-title":"Drugs Aging"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120302776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120302776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:51:35Z","timestamp":1761544295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120302776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1544319120302776"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.011","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating trajectories of statin adherence after a motivational interviewing intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}